Multiplex Assays Market Size, Share, Revenue, Trends And Drivers For 2024-2033

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033

LONDON, GREATER LONDON , UK, July 19, 2024 /EINPresswire.com/ -- The multiplex assays market has experienced robust growth in recent years, expanding from $3.61 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increased healthcare expenditure, emerging markets growth, rapid technological advances, and a rapid growth in the aging population.

Strong Future Growth Anticipated
The multiplex assays market is projected to continue its strong growth, reaching $5.7 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the rise in funding, government initiatives for genetic and microbiological research, aging population, increasing prevalence of chronic diseases and a rapid rise in various bacterial and viral epidemics. Major trends in the forecast period include the rise in funding, government initiatives for genetic and microbiological research, the aging population, the increasing prevalence of chronic diseases, and a rapid rise in various bacterial and viral epidemics.

Explore Comprehensive Insights Into The Global Multiplex Assays Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=5775&type=smp

Growth Driver Of The Multiplex Assays Market
An increased incidence of chronic diseases is driving the growth of the global multiplex assay market. Multiplex assay is extensively used in clinical trials to analyze and study the efficacy of a disease and for the detection of antibodies against those diseases.

Make Your Report Purchase Here And Explore The Whole Industry's Data As Well:
https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

Multiplex Assays Market Major Players And Market Trends
Key players in the multiplex assays market include Seegene Inc., DiaSorin SpA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen NV, Abcam PLC, PerkinElmer Inc., Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd., bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics.
Companies in the market are launching innovative tests based on multiplex assays to strengthen their position in the market.

Multiplex Assays Market Segments:
1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types
2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies
3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies
4) By Application: Research And Development, Clinical Diagnostics
5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

Geographical Insights: North America Leading The Market
North America was the largest region in the multiplex assays market in 2023.

Multiplex Assays Market Definition
Multiplex assays are used to amplify multiple targets in a polymerase chain response (PCR) trial and collect further information from nanosecond amounts of proteins or other analyses in lower time as compared to the conventional system, similar to ELISA. Multiplex assays are used for pathogen identification, mutation analysis, RNA discovery, gene discovery analysis, relation analysis, forensic studies, and others.

Multiplex Assays Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Multiplex Assays Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on multiplex assays market size, multiplex assays market drivers and trends, multiplex assays market major players, multiplex assays competitors' revenues, multiplex assays market positioning, and multiplex assays market growth across geographies. The multiplex assays market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Neurodegenerative Disorder Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurology Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn